نتائج البحث - "Ken Uchibori"

1

Monitoring epidermal growth factor receptor C797S mutation in Japanese non–small cell lung cancer patients with serial cell‐free DNA evaluation using digital droplet PCR

المؤلفون: Yusuke Ono, Ryohei Katayama, Noriko Yanagitani, Ken Uchibori, Makoto Nishio, Satoru Kitazono, Ryo Ariyasu, Ryohei Yoshida, Yusuke Mizukami, Mika Tsukahara, Takaaki Sasaki, Kazuma Kiyotani, Yuichi Ishikawa, Naoya Fujita, Hironori Ninomiya

المصدر: Cancer Science

مصطلحات موضوعية: 0301 basic medicine, Neuroblastoma RAS viral oncogene homolog, Male, Cancer Research, Lung Neoplasms, T790M, Polymerase Chain Reaction, droplet digital PCR, GTP Phosphohydrolases, 0302 clinical medicine, Japan, Carcinoma, Non-Small-Cell Lung, Osimertinib, Digital polymerase chain reaction, Epidermal growth factor receptor, Trametinib, Aniline Compounds, biology, High-Throughput Nucleotide Sequencing, General Medicine, Middle Aged, ErbB Receptors, Oncology, 030220 oncology & carcinogenesis, osimertinib, Cohort, Disease Progression, Original Article, Female, Cell-Free Nucleic Acids, C797S, EGFR, resistance, 03 medical and health sciences, Clinical Research, Cell Line, Tumor, medicine, Humans, Lung cancer, Aged, Acrylamides, business.industry, Membrane Proteins, Original Articles, Sequence Analysis, DNA, medicine.disease, respiratory tract diseases, 030104 developmental biology, Drug Resistance, Neoplasm, Mutation, Cancer research, biology.protein, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a277e2cabf966445372f837b9fc33b98Test
http://europepmc.org/articles/PMC8177776Test

2

Clinical influence of switching companion diagnostic tests for EGFR‐TKs from Therascreen to Cobas v2

المؤلفون: Ryo Ariyasu, Hiroshi Yoshida, Hiroaki Sakamoto, Satoru Kitazono, Natsuki Takano, Makoto Nishio, Ryosuke Tsugitomi, Yoshiaki Amino, Ryo Manabe, Ken Uchibori, Shinsuke Ogusu, Noriko Yanagitani, Takehiro Tozuka

المصدر: Thoracic Cancer, Vol 12, Iss 6, Pp 906-913 (2021)
Thoracic Cancer

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Future studies, next‐generation sequencing (NGS), lcsh:RC254-282, Young Adult, 03 medical and health sciences, T790M, 0302 clinical medicine, Internal medicine, medicine, Humans, Osimertinib, In patient, Lung cancer, Protein Kinase Inhibitors, EGFR‐TKI, Aged, Aged, 80 and over, Diagnostic Tests, Routine, business.industry, Cancer, Original Articles, General Medicine, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, ErbB Receptors, Companion diagnostic (CDx), 030104 developmental biology, Egfr mutation, 030220 oncology & carcinogenesis, polymerase chain reaction (PCR), Original Article, Female, EGFR mutation, business, Companion diagnostic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b4b8e6ae7a1f05a33f62f905a01ce39Test
https://doi.org/10.1111/1759-7714.13797Test

3

Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice

المؤلفون: Shinsuke Ogusu, Makoto Nishio, Satoru Kitazono, Ryo Ariyasu, Hironori Ninomiya, Noriko Yanagitani, Takehiro Tozuka, Yoshiaki Amino, Kengo Takeuchi, Ryo Manabe, Hiroaki Sakamaoto, Ryosuke Tsugitomi, Ken Uchibori, Hiroshi Yoshida

المصدر: Thoracic Cancer
Thoracic Cancer, Vol 12, Iss 4, Pp 504-511 (2021)

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, real‐world analysis, Carcinoma, Non-Small-Cell Lung, Internal medicine, Biopsy, medicine, Humans, Biopsy procedure, turnaround time, Aged, Aged, 80 and over, medicine.diagnostic_test, business.industry, High-Throughput Nucleotide Sequencing, Original Articles, General Medicine, Middle Aged, Surgical procedures, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cobas EGFR mutation test, Clinical trial, Sample quality, Clinical Practice, ALK‐immunohistochemistry, 030104 developmental biology, Egfr mutation, 030220 oncology & carcinogenesis, Female, Original Article, Non small cell, business, Oncomine Dx Target test

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d028c4cf5d1a05a14610be4783d3204Test
https://doi.org/10.1111/1759-7714.13786Test

4

Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer

المؤلفون: Ryo Ariyasu, Noriko Yanagitani, Fumiyoshi Ohyanagi, Ken Uchibori, Tsukasa Hasegawa, Makoto Nishio, Keita Kudo, Shingo Nishikawa, Yuichi Tambo, Atsushi Horiike, Satoru Kitazono

المصدر: International Journal of Clinical Oncology. 26:507-514

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6d6f784915f0cfcebc80ffafd4cfc39dTest
https://doi.org/10.1007/s10147-020-01822-7Test

5

Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases

المؤلفون: Tsukasa Hasegawa, Ryo Ariyasu, Masahiro Seike, Makoto Nishio, Takeshi Horai, Hiroshi Yoshida, Noriko Yanagitani, Akihiko Gemma, Ken Uchibori, Takehiro Tozuka, Satoru Kitazono, Yoshiaki Amino, Takahiro Yoshizawa, Hiroaki Sakamoto, Shinya Uematsu

المصدر: Thoracic Cancer
Thoracic Cancer, Vol 11, Iss 9, Pp 2465-2472 (2020)

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Lung Neoplasms, medicine.medical_treatment, immune checkpoint inhibitor, B7-H1 Antigen, central nervous system metastases, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, brain metastases, Programmed cell death 1, Medicine, Aged, 80 and over, biology, Brain Neoplasms, digestive, oral, and skin physiology, General Medicine, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 030220 oncology & carcinogenesis, Female, Original Article, Non small cell, medicine.symptom, Antibody, Adult, Pulmonary and Respiratory Medicine, medicine.medical_specialty, education, lcsh:RC254-282, Anti PD‐1/PD‐L1 antibody, Asymptomatic, 03 medical and health sciences, Internal medicine, Humans, Poor performance status, Lung cancer, Aged, Retrospective Studies, business.industry, Retrospective cohort study, Original Articles, Immunotherapy, medicine.disease, stomatognathic diseases, 030104 developmental biology, biology.protein, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8f1ff75d1a1081b9e457351f91678f9Test
https://doi.org/10.1111/1759-7714.13557Test

6

Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non‐small cell lung cancer

المؤلفون: Mika Tsukahara, Koutaroh Okada, Ryohei Katayama, Noriko Yanagitani, Makoto Nishio, Kenichi Okubo, Ken Uchibori, Ken Takahashi, Yosuke Seto, Naoya Fujita, Shinya Uematsu, Tomoko Oh-hara

المصدر: Thoracic Cancer, Vol 11, Iss 3, Pp 581-587 (2020)
Thoracic Cancer

مصطلحات موضوعية: 0301 basic medicine, Alectinib, Lung Neoplasms, Apoptosis, next‐generation sequence, 0302 clinical medicine, Piperidines, Carcinoma, Non-Small-Cell Lung, hemic and lymphatic diseases, Tumor Cells, Cultured, Anaplastic lymphoma kinase, Medicine, Anaplastic Lymphoma Kinase, Sulfones, ALK compound mutation, Sanger sequencing, General Medicine, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Oncology, 030220 oncology & carcinogenesis, symbols, Original Article, Female, medicine.drug, Pulmonary and Respiratory Medicine, non‐small cell lung cancer, Brigatinib, Carbazoles, lcsh:RC254-282, 03 medical and health sciences, symbols.namesake, Organophosphorus Compounds, Crizotinib, Humans, Lung cancer, Protein Kinase Inhibitors, Aged, Cell Proliferation, Ceritinib, business.industry, Original Articles, medicine.disease, Lorlatinib, 030104 developmental biology, Pyrimidines, Drug Resistance, Neoplasm, Mutation, Cancer research, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::435113d9a070a711eacc79dd3055f9b4Test
https://doaj.org/article/8eb722c532b94cce883b69c0048498a1Test

7

Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms

المؤلفون: Ryohei Katayama, Noriko Yanagitani, Fumiyoshi Ohyanagi, Mika Tsukahara, Makoto Nishio, Naoya Fujita, Yuichi Tambo, Sumie Koike, Atsushi Horiike, Satoru Kitazono, Takahiro Yoshizawa, Shingo Nishikawa, Ken Uchibori

المصدر: Cancer Science

مصطلحات موضوعية: 0301 basic medicine, Alectinib, Cancer Research, Lung Neoplasms, Lactams, Lactams, Macrocyclic, Carbazoles, Aminopyridines, Drug resistance, 03 medical and health sciences, tyrosine kinase inhibitor, 0302 clinical medicine, Asian People, Crizotinib, Piperidines, Clinical Research, Carcinoma, Non-Small-Cell Lung, hemic and lymphatic diseases, medicine, Humans, Anaplastic lymphoma kinase, Anaplastic Lymphoma Kinase, Sulfones, Progression-free survival, Lung cancer, Protein Kinase Inhibitors, Ceritinib, business.industry, progression‐free survival, Original Articles, General Medicine, medicine.disease, Lorlatinib, Recombinant Proteins, respiratory tract diseases, Pyrimidines, 030104 developmental biology, Oncology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Mutation, Cancer research, Pyrazoles, Original Article, business, resistance mechanism, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b2406885a5cd0179f5722a930abe6adTest
https://doi.org/10.1111/cas.14314Test

8

Efficacy of anti-PD-1 therapy for recurrence after chemoradiotherapy in locally advanced NSC LC

المؤلفون: Takahiro Yoshizawa, Tsukasa Hasegawa, Kazuo Kasahara, Shinya Uematsu, Takeshi Horai, Makoto Nishio, Satoru Kitazono, Ken Uchibori, Noriko Yanagitani, Atsushi Horiike, Yoshiaki Amino

المصدر: International Journal of Clinical Oncology. 25:67-73

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Locally advanced, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Surgical oncology, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, Adverse effect, Aged, Retrospective Studies, Pneumonitis, Chemotherapy, business.industry, Standard treatment, Anti pd 1, Chemoradiotherapy, Hematology, General Medicine, Middle Aged, medicine.disease, Survival Analysis, Treatment Outcome, 030104 developmental biology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Surgery, Neoplasm Recurrence, Local, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3bfafdc96519c9dac691a5390e3448cTest
https://doi.org/10.1007/s10147-019-01537-4Test

9

Correlation between thyroid transcription factor-1 expression, immune-related thyroid dysfunction, and efficacy of anti-programmed cell death protein-1 treatment in non-small cell lung cancer

المؤلفون: Atsushi Horiike, Noriko Yanagitani, Takahiro Yoshizawa, Shingo Nishikawa, Ryo Ariyasu, Junji Koyama, Ken Uchibori, Tomoaki Sonoda, Makoto Nishio, Hironori Ninomiya, Yosuke Dotsu, Masafumi Saiki, Yuichi Ishikawa, Satoru Kitazono

المصدر: Journal of Thoracic Disease. 11:1919-1928

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd1ce2a8bb1c0340835f56148a7dcd60Test
https://doi.org/10.21037/jtd.2019.04.102Test

10

Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations

المؤلفون: Miyako Satouchi, Ken Uchibori, Motoko Tachihara, Chiyuki Kokan, Yoshiko Urata, Keisuke Aoe, Kazuyuki Kobayashi, Kentaro Iwanaga, Akemi Sato, Naoko Sueoka-Aragane, Satoshi Morita, Tomonori Hirashima, Nobuyuki Katakami, Shunichi Negoro, Takako Inoue, Fumio Imamura, Masahide Mori

المصدر: Lung Cancer. 124:65-70

مصطلحات موضوعية: Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Pemetrexed, Gene mutation, 03 medical and health sciences, T790M, 0302 clinical medicine, Gefitinib, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Osimertinib, Epidermal growth factor receptor, Lung cancer, Aged, Neoplasm Staging, Aged, 80 and over, biology, business.industry, Middle Aged, medicine.disease, Progression-Free Survival, respiratory tract diseases, ErbB Receptors, 030104 developmental biology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Mutation, biology.protein, Female, Neoplasm Recurrence, Local, business, Progressive disease, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4104cdcde8f376c37e0e4f1a5a4da861Test
https://doi.org/10.1016/j.lungcan.2018.07.031Test

تنقيح النتائج